CClinicalTrials.gg
CompletedNCT06415630ADreintubateUpdated May 16, 2024

Prediction Models for Postoperative Reintubation in Patients With Acute Aortic Dissection

An observational study in Nomogram, Prediction Model and Type A Aortic Dissection, sponsored by Wuhan Union Hospital, China. Completed at 1 site in China. Open to participants aged 19 Years to 90 Years. Per ClinicalTrials.gov, last updated 2024-05-16.

Sponsored by Wuhan Union Hospital, China · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
861
Ages
19 Years to 90 Years
Sex
All
01

Study summary

Reintubation is an adverse postoperative complication in patients with Type A aortic dissection (AAD) that correlates to poor outcomes. This study aims to analyze the risk factors associated with reintubation and to create a fully automated score model to predict the incidence of reintubation. A total of 861 patients diagnosed with AAD and undergoing surgical procedures in a single institution between January 2018 and October 2023 were selected in wuhan Union Hospital. Preoperative and postoperative informmation was used for seeking risk factors and build prediction model for postoperative reintubation. Finally, 5 risk factors wasidentified and a nomogram was established for predicting postoperative reintubation in patients with AAD.

02

Conditions studied

  • Nomogram
  • Prediction Model
  • Type A Aortic Dissection
  • Postoperative Reintubation

Browse trials for

03

In context

Aortic Dissection

386 studies on the registry are indexed under Aortic Dissection; 117 are open to participants now.

This study's enrollment of 861 is above the median of 183 across 180 observational studies indexed under Aortic Dissection.

Browse Aortic Dissection studies →

Lead sponsor

Wuhan Union Hospital, China is the lead sponsor of 230 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 90 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

A total of 892 patients with AAD who underwent open surgery at Wuhan Union Hospital between January 2018 and October 2023 were enrolled using a convenient sampling method.

Inclusion criteria

(1) patients diagnosed with AAD admitted for open surgery; (2) aged 18 years or older.

Exclusion criteria

Exclusion Criteria:

(1) patients deceased during or within 24 hours after surgery; (2) patients with preoperative intubation.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
861 participants (actual)
Patient registry
No

Groups and cohorts

  • training group

    To determine potential predictive factors, the training group was subjected to LASSO regression analysis, which effectively eliminated several irrelevant or multicollinearity independent variables to reduce high-dimensional data.Seven models were initially constructed in the training group: multivariable logistics regression (MLR), decision-tree modeling, random forest, XGBoost, Support Vector Machines, k-nearest neighbors, and LightGBM.

    Procedure: Type A aortic dissection surgery

  • testing group

    Testing group was used to examine the performance of the seven prediction models, including discrimination and calibration performance. Finally, the model with best discrimination and calibration performance was used to construct nomogram for predicting reintubation.

    Procedure: Type A aortic dissection surgery

Interventions

  • ProcedureType A aortic dissection surgery

    Patients with type A aortic dissection undergone surgery.

06

What researchers measure

Primary outcomes

  1. postoperative reintubation

    reintubation incidence in patients with type A aortic dissection undergoing surgery

    Time frame: 3 month

07

Study locations

1 site
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei 430022, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06415630
Lead sponsor
Wuhan Union Hospital, China
Responsible party
Sponsor
First posted
May 16, 2024
Start date
Jan 1, 2018
Primary completion
Oct 31, 2023
Completion
Dec 31, 2023
Last update
May 16, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion